These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10636375)

  • 1. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.
    Lancet; 1999 Dec; 354(9195):2050-1. PubMed ID: 10636375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.
    Dabis F; Msellati P; Meda N; Welffens-Ekra C; You B; Manigart O; Leroy V; Simonon A; Cartoux M; Combe P; Ouangré A; Ramon R; Ky-Zerbo O; Montcho C; Salamon R; Rouzioux C; Van de Perre P; Mandelbrot L
    Lancet; 1999 Mar; 353(9155):786-92. PubMed ID: 10459959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.
    Wiktor SZ; Ekpini E; Karon JM; Nkengasong J; Maurice C; Severin ST; Roels TH; Kouassi MK; Lackritz EM; Coulibaly IM; Greenberg AE
    Lancet; 1999 Mar; 353(9155):781-5. PubMed ID: 10459958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.
    Leroy V; Karon JM; Alioum A; Ekpini ER; van de Perre P; Greenberg AE; Msellati P; Hudgens M; Dabis F; Wiktor SZ;
    AIDS; 2003 Jul; 17(10):1493-501. PubMed ID: 12824787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.
    Lallemant M; Jourdain G; Le Coeur S; Kim S; Koetsawang S; Comeau AM; Phoolcharoen W; Essex M; McIntosh K; Vithayasai V
    N Engl J Med; 2000 Oct; 343(14):982-91. PubMed ID: 11018164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine and reduction of vertical transmission of HIV in Africa. ANRS 049 Trial Group.
    Msellati P; Meda N; Welffens-Ekra C; Leroy V; Van de Perre P; Mandelbrot L; Dabis F
    Am J Public Health; 1999 Jun; 89(6):947-8. PubMed ID: 10358695
    [No Abstract]   [Full Text] [Related]  

  • 7. Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa.
    Meda N; Leroy V; Viho I; Msellati P; Yaro S; Mandelbrot L; Montcho C; Manigart O; Dabis F;
    AIDS; 2002 Nov; 16(17):2323-8. PubMed ID: 12441805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
    Simonds RJ; Rogers MF; Dondero TJ
    N Engl J Med; 1998 Mar; 338(12):836-7; author reply 840-1. PubMed ID: 9508628
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
    Petra Study Team
    Lancet; 2002 Apr; 359(9313):1178-86. PubMed ID: 11955535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa.
    Leroy V; Karon JM; Alioum A; Ekpini ER; Meda N; Greenberg AE; Msellati P; Hudgens M; Dabis F; Wiktor SZ;
    AIDS; 2002 Mar; 16(4):631-41. PubMed ID: 11873008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.
    Jamieson DJ; Sibailly TS; Sadek R; Roels TH; Ekpini ER; Boni-Ouattara E; Karon JM; Nkengasong J; Greenberg AE; Wiktor SZ
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):430-6. PubMed ID: 14615662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.
    Leroy V; Montcho C; Manigart O; Van de Perre P; Dabis F; Msellati P; Meda N; You B; Simonon A; Rouzioux C;
    AIDS; 2001 Mar; 15(4):517-22. PubMed ID: 11242149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99.
    Msellati P; Hingst G; Kaba F; Viho I; Welffens-Ekra C; Dabis F
    Bull World Health Organ; 2001; 79(7):641-7. PubMed ID: 11477967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Jackson JB; Musoke P; Fleming T; Guay LA; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Owor M; Ducar C; Deseyve M; Mwatha A; Emel L; Duefield C; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Gigliotti M; Bray D; Mmiro F
    Lancet; 2003 Sep; 362(9387):859-68. PubMed ID: 13678973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tackling mother-to-child HIV in Côte d'Ivoire.
    Feinmann J
    Lancet; 1997 Oct; 350(9084):1084. PubMed ID: 10213564
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Chuachoowong R; Mock PA; Bhadrakom C; Siriwasin W; Young NL; Chotpitayasunondh T; Chearskul S; Roongpisuthipong A; Chinayon P; Karon J; Mastro TD; Simonds RJ
    Lancet; 1999 Mar; 353(9155):773-80. PubMed ID: 10459957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No adverse effects in infants following short-course zidovudine.
    AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279877
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short course of AZT halves HIV-1 perinatal transmission.
    Morris K
    Lancet; 1998 Feb; 351(9103):651. PubMed ID: 9500334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.